A Study to Evaluate the Long-term Use of Valsartan in Children 6 Months to 5 Years Old With Hypertension

PHASE3CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

April 9, 2007

Primary Completion Date

May 25, 2009

Study Completion Date

May 25, 2009

Conditions
Hypertension
Interventions
DRUG

Valsartan

Extemporaneous suspension of valsartan, orally.

Trial Locations (36)

1020

Novartis Investigative Site, Laken

2020

Novartis Investigative Site, Antwerp

2650

Novartis Investigative Site, Edegem

4000

Novartis Investigative Site, Liège

7505

Novartis Investigative Site, Cape Town

9000

Novartis Investigative Site, Ghent

10126

Novartis Investigative Site, Torino

13385

Novartis Investigative Site, Marseille

19104

Novartis Investigative Site, Philadelphia

23510

Novartis Investigative Site, Norfolk

31026

Novartis Investigative Site, Toulouse

35040

Novartis Investigative Site, Izmir

75935

Novartis Investigative Site, Paris

90134

Novartis Investigative Site, Palermo

400026

Novartis Investigative Site, Mumbai

425001

Novartis Investigative Site, Indore

500033

Novartis Investigative Site, Hyderabad

575001

Novartis Investigative Site, Mangalore

600008

Novartis Investigative Site, Chennai

07601

Novartis Investigative Site, Hackensack

74605-050

Novartis Investigative Site, Goiânia

80250-030

Novartis Investigative Site, Curitiba

50070-050

Novartis Investigative Site, Recife

H-1083

Novartis Investigative Site, Budapest

H-6720

Novartis Investigative Site, Szeged

110 029

Novartis Investigative Site, New Delhi

80-952

Novartis Investigative Site, Gdansk

30-663

Novartis Investigative Site, Krakow

93-338

Novartis Investigative Site, Lodz

60-572

Novartis Investigative Site, Poznan

70-410

Novartis Investigative Site, Szczecin

04-730

Novartis Investigative Site, Warsaw

0084

Novartis Investigative Site, Gezina

Unknown

Novartis Investigative Site, Potchefstroom

0002

Novartis Investigative Site, Pretoria

06100

Novartis Investigative Site, Ankara

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY